2016 annual financial data
Sarepta Therapeutics 2016 Operating cash flow margin
Direct answer
Operating cash flow margin was -4,534.59%.
Operating income was -266,730,000 USD and net income was -267,265,000 USD.
Operating cash flow was -245,820,000 USD.
Get free Sarepta Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,421,000 USD
- Operating income
- -266,730,000 USD
- Net income
- -267,265,000 USD
- Operating cash flow
- -245,820,000 USD